1World Health Organization. International of Hypertension Society Writing Group. 2003 World Health Organization (WHO)/International Society Hypertension Writing (ISH) statement on management of hypertension. J Hypertens,2003,21:1983-1992. 被引量：1
1Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens, 1999, 17∶151-183. 被引量：1
2National Institutes of Health, National Heart, Lung, and Blood Institute. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med, 1997, 157∶2413-2446.[Erratum, Arch Int 被引量：1
3Karch F, Lasagna L. Adverse drug reactions: a critical review. JAMA,1975,234∶1236-1241. 被引量：1
4Lip GYH, Beevers DG. A survey of the current practice of treating hypertension in primary care: the rational evaluation and choice in hypertension (REACH) study. J Drug Devel Clin Pract, 1996, 8∶161-169. 被引量：1
5Payne KA, Esmonde-White S. Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence? Curr Hypertens Rep, 2000,2∶515-524. 被引量：1
6Dusing R, Weisser B, Mengden T, et al. Changes in antihypertensive therapy-the role of adverse effects and compliance. Blood Press, 1998,7∶313-315. 被引量：1
7Conlin PR, Gerth WC, Fox J, et al. Four-year persistence patterns among patients initiating therapy with the angiotensin Ⅱ receptor antagonist losartan versus other antihypertensive drug classes. Clin Ther, 2001,23∶1999-2010. 被引量：1
8Benson S, Vance-Bryan K, Raddatz J. Time to patient discontinuation of antihypertensive drugs in difference classes. Am J Health Syst Pharm, 2000,57∶51-54. 被引量：1
9Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis. JAMA, 1997,277∶739-745. 被引量：1
10Ames RP. A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides. Am J Cardiol, 1996,77∶12B-16B. 被引量：1
3Maksic DJ.Correlation of inflammatory cytokines in the urine and serum with clinico-laboratory and pathohistologic features in patients with IgA nephmpathy.Srp Arh Cdok Lek,2006,124:37. 被引量：1
4World health organization. International of hyper- tension society writing group. 2003 world health organization (who)/international society hyperten- sion writing statement on management of hyperten- sion[J].Hypertens,2003,21:1983-1992. 被引量：1
